Australia markets closed

Eli Lilly and Company (0Q1G.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
540.00+295.04 (+120.45%)
At close: 04:18PM BST
Full screen
Previous close244.96
Bid0.00 x N/A
Ask0.00 x N/A
Day's range0.00 - 0.00
52-week range
Avg. volume4,996
Market cap491.119B
Beta (5Y monthly)0.41
PE ratio (TTM)0.83
EPS (TTM)6.52
Earnings date08 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Yahoo Finance

    Healthcare stocks at an 'inflection point,' analyst says

    Earnings for healthcare companies have declined for six straight quarters. But analysts have a more positive outlook going into second quarter earnings.

  • Yahoo Finance Video

    Jobless claims, healthcare, small caps: Trading Takeaways

    US weekly jobless claims rose more than expected as leadership from the Federal Reserve has expressed confidence in bringing inflation down. The healthcare sector (XLV) slumped today, leading in sector losses and dropping by over 2%. Lastly, the run that small caps (^RUT) has seen in the past few days has begun to stall out, erasing much of the gains from earlier in the week. Yahoo Finance markets reporter Josh Schafer joins Asking For A Trend to break down the latest market trends for July 18. For more expert insight and the latest market action, click here to watch this full episode. This post was written by Nicholas Jacobino

  • Investor's Business Daily

    Is Eli Lilly Stock A Sell On A Rare Stumble In Obesity Treatment?

    Is Eli Lilly stock a buy after shares have leveraged a comeback following the acquisition of Morphic and positive weight-loss drug news?